Pharmaceutical Preparations

Abstract

Pharmaceutical preparations are proposed, comprising bitter-masking acting substances for reducing and/or inhibiting gastric acid secretion induced by food constituents.

1 .- 15 . (canceled) 
     
     
         16 . A method for reducing and/or inhibiting secretion of gastric acid induced by food constituents, comprising:
 administering a gastric acid-inhibiting substance selected from the group consisting of homoeriodictyol and/or eriodictyol to a human who has previously consumed a gastric acid-stimulating component selected from the group consisting of caffeine, theobromine and mixtures thereof and wherein the gastric acid-inhibiting substance is administered prior to gastric acid stimulation in the human by the gastric acid-stimulating component and which is in an amount which inhibits the gastric acid-stimulating effect of the gastric acid-stimulating component in the person.   
     
     
         17 . The method of  claim 16 , wherein the gastric acid-inhibiting substance is administered in amounts of from 0.1 mg/kg to 1,000 mg/kg. 
     
     
         18 . The method of  claim 16 , wherein the gastric acid-inhibiting substance is administered in amounts of from 0.1 mg/kg to 500 mg/kg. 
     
     
         19 . The method of  claim 16 , wherein the gastric acid-inhibiting substance is administered in amounts of from 0.1 mg/kg to 100 mg/kg. 
     
     
         20 . The method of  claim 16 , wherein the gastric acid-inhibiting substance is administered in
 an orally consumable preparation selected from the group consisting of capsules, tablets, sugar-coated   pills, granules, pellets, mixtures of solids, emulsions, powders, and pastes.   
     
     
         21 . The method of  claim 16 , wherein the gastric acid-stimulating component is caffeine. 
     
     
         22 . The method of  claim 16 , wherein the gastric acid-stimulating component is theobromine. 
     
     
         23 . The method of  claim 16 , wherein the gastric acid-inhibiting substance is administered in
 an orally consumable preparation which is in the form which causes delayed release.   
     
     
         24 . The method of  claim 16 , wherein the gastric acid-stimulating component is present in a
 preparation selected from the group consisting of bakery products, confectionery, alcoholic or   non-alcoholic drinks, meat products, eggs or egg products, cereal products, milk products,   products made from soy protein or other soybean fractions, fruit preparations, vegetable   preparations, snack foods, products based on fat and oil or emulsions of the same, other ready   meals and soups, spices, spice mixtures and seasonings.